Physician profile
Connor Barnes
NPI 1568881407
$4,478.85
in general payments reported to CMS, 2019-2025
17 companies · $286 in 2025
The $286 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $296 · 2020: $36.61 · 2021: $1,331 · 2022: $1,804 · 2023: $217 · 2024: $509 · 2025: $286.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,011.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,011.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sientra, INC. | $1,842.35 | 2021-2022 | |
| Mentor Worldwide LLC | $989.90 | 2021-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Davol INC. | $324.85 | 2022-2024 | Arista Ah Flexitip |
| Allergan, INC. | $285.05 | 2021-2022 | |
| Abbvie INC. | $260.96 | 2023-2025 | Natrelle Saline-Filled Breast Implants |
| Tepha INC | $175.72 | 2019 | |
| Motiva USA, LLC | $137.15 | 2025 | |
| Acelrx Pharmaceuticals, INC. | $120.48 | 2019 | |
| Kerecis Limited | $70.12 | 2020-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Integra Lifesciences Corporation | $53.94 | 2023 | Durasorb Monofilament Mesh |
| Solventum Corporation | $53.48 | 2024-2025 | Prevena, V.A.C.Ulta, V.A.C. Granufoam |
| Tela Bio, INC. | $49.05 | 2022 | |
| Polynovo North America LLC | $32.38 | 2021 | |
| Depuy Synthes Sales INC. | $24.75 | 2021 | |
| Endo Pharmaceuticals INC. | $24.06 | 2024 | Xiaflex |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $17.80 | 2020 | |
| Biocomposites INC | $16.81 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Connor Barnes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.